{
     "PMID": "28899992",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20171010",
     "LR": "20171010",
     "IS": "1521-0103 (Electronic) 0022-3565 (Linking)",
     "VI": "363",
     "IP": "2",
     "DP": "2017 Nov",
     "TI": "Depletion of Progranulin Reduces GluN2B-Containing NMDA Receptor Density, Tau Phosphorylation, and Dendritic Arborization in Mouse Primary Cortical Neurons.",
     "PG": "164-175",
     "LID": "10.1124/jpet.117.242164 [doi]",
     "AB": "Loss-of-function mutations in the progranulin (PGRN) gene are a common cause of familial frontotemporal lobar degeneration (FTLD). This age-related neurodegenerative disorder, characterized by brain atrophy in the frontal and temporal lobes and such typical symptoms as cognitive and memory impairment, profound behavioral abnormalities, and personality changes is thought to be related to connectome dysfunctions. Recently, PGRN reduction has been found to induce a behavioral phenotype reminiscent of FTLD symptoms in mice by affecting neuron spine density and morphology, suggesting that the protein can influence neuronal structural plasticity. Here, we evaluated whether a partial haploinsufficiency-like PGRN depletion, achieved by using RNA interference in primary mouse cortical neurons, could modulate GluN2B-containing N-methyl-d-aspartate (NMDA) receptors and tau phosphorylation, which are crucially involved in the regulation of the structural plasticity of these cells. In addition, we studied the effect of PGRN decrease on neuronal cell arborization both in the presence and absence of GluN2B-containing NMDA receptor stimulation. We found that PGRN decline diminished GluN2B-containing NMDA receptor levels and density as well as NMDA-dependent tau phosphorylation. These alterations were accompanied by a marked drop in neuronal arborization that was prevented by an acute GluN2B-containing NMDA receptor stimulation. Our findings support that PGRN decrease, resulting from pathogenic mutations, might compromise the trophism of cortical neurons by affecting GluN2B-contaning NMDA receptors. These mechanisms might be implicated in the pathogenesis of FTLD.",
     "CI": [
          "Copyright (c) 2017 by The American Society for Pharmacology and Experimental",
          "Therapeutics."
     ],
     "FAU": [
          "Longhena, Francesca",
          "Zaltieri, Michela",
          "Grigoletto, Jessica",
          "Faustini, Gaia",
          "La Via, Luca",
          "Ghidoni, Roberta",
          "Benussi, Luisa",
          "Missale, Cristina",
          "Spano, PierFranco",
          "Bellucci, Arianna"
     ],
     "AU": [
          "Longhena F",
          "Zaltieri M",
          "Grigoletto J",
          "Faustini G",
          "La Via L",
          "Ghidoni R",
          "Benussi L",
          "Missale C",
          "Spano P",
          "Bellucci A"
     ],
     "AUID": [
          "ORCID: http://orcid.org/0000-0001-6569-9412",
          "ORCID: http://orcid.org/0000-0003-3468-4546",
          "ORCID: http://orcid.org/0000-0002-0751-3082",
          "ORCID: http://orcid.org/0000-0002-7691-1957",
          "ORCID: http://orcid.org/0000-0003-2836-8141",
          "ORCID: http://orcid.org/0000-0003-4944-1467",
          "ORCID: http://orcid.org/0000-0002-9906-0964",
          "ORCID: http://orcid.org/0000-0002-9581-1919"
     ],
     "AD": "Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy (F.L, M.Z., J.G., G.F., L.L.V., C.M., P.S., A.B.) and Molecular Markers Laboratory, IRCCS Instituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy (R.G., L.B.). Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy (F.L, M.Z., J.G., G.F., L.L.V., C.M., P.S., A.B.) and Molecular Markers Laboratory, IRCCS Instituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy (R.G., L.B.). Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy (F.L, M.Z., J.G., G.F., L.L.V., C.M., P.S., A.B.) and Molecular Markers Laboratory, IRCCS Instituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy (R.G., L.B.). Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy (F.L, M.Z., J.G., G.F., L.L.V., C.M., P.S., A.B.) and Molecular Markers Laboratory, IRCCS Instituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy (R.G., L.B.). Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy (F.L, M.Z., J.G., G.F., L.L.V., C.M., P.S., A.B.) and Molecular Markers Laboratory, IRCCS Instituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy (R.G., L.B.). Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy (F.L, M.Z., J.G., G.F., L.L.V., C.M., P.S., A.B.) and Molecular Markers Laboratory, IRCCS Instituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy (R.G., L.B.). Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy (F.L, M.Z., J.G., G.F., L.L.V., C.M., P.S., A.B.) and Molecular Markers Laboratory, IRCCS Instituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy (R.G., L.B.). Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy (F.L, M.Z., J.G., G.F., L.L.V., C.M., P.S., A.B.) and Molecular Markers Laboratory, IRCCS Instituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy (R.G., L.B.). Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy (F.L, M.Z., J.G., G.F., L.L.V., C.M., P.S., A.B.) and Molecular Markers Laboratory, IRCCS Instituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy (R.G., L.B.). Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy (F.L, M.Z., J.G., G.F., L.L.V., C.M., P.S., A.B.) and Molecular Markers Laboratory, IRCCS Instituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy (R.G., L.B.) arianna.bellucci@unibs.it.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20170912",
     "PL": "United States",
     "TA": "J Pharmacol Exp Ther",
     "JT": "The Journal of pharmacology and experimental therapeutics",
     "JID": "0376362",
     "RN": [
          "0 (Grn protein, mouse)",
          "0 (Intercellular Signaling Peptides and Proteins)",
          "0 (NR2B NMDA receptor)",
          "0 (Receptors, N-Methyl-D-Aspartate)",
          "0 (tau Proteins)"
     ],
     "SB": "IM",
     "MH": [
          "Aging",
          "Animals",
          "Base Sequence",
          "Cell Survival",
          "Cerebral Cortex/*cytology",
          "Gene Expression Regulation",
          "Glycosylation",
          "Hippocampus/cytology",
          "Intercellular Signaling Peptides and Proteins/chemistry/*deficiency/genetics/metabolism",
          "Mice",
          "Mice, Inbred C57BL",
          "Molecular Weight",
          "*Neuronal Plasticity",
          "Neurons/cytology/*metabolism",
          "Phosphorylation",
          "*RNA Interference",
          "Receptors, N-Methyl-D-Aspartate/*metabolism",
          "tau Proteins/*metabolism"
     ],
     "EDAT": "2017/09/14 06:00",
     "MHDA": "2017/10/11 06:00",
     "CRDT": [
          "2017/09/14 06:00"
     ],
     "PHST": [
          "2017/09/14 06:00 [pubmed]",
          "2017/10/11 06:00 [medline]",
          "2017/09/14 06:00 [entrez]"
     ],
     "AID": [
          "jpet.117.242164 [pii]",
          "10.1124/jpet.117.242164 [doi]"
     ],
     "PST": "ppublish",
     "SO": "J Pharmacol Exp Ther. 2017 Nov;363(2):164-175. doi: 10.1124/jpet.117.242164. Epub 2017 Sep 12.",
     "term": "hippocampus"
}